AU2004252258A1 - Method for dosing a biological or chemical sample - Google Patents
Method for dosing a biological or chemical sample Download PDFInfo
- Publication number
- AU2004252258A1 AU2004252258A1 AU2004252258A AU2004252258A AU2004252258A1 AU 2004252258 A1 AU2004252258 A1 AU 2004252258A1 AU 2004252258 A AU2004252258 A AU 2004252258A AU 2004252258 A AU2004252258 A AU 2004252258A AU 2004252258 A1 AU2004252258 A1 AU 2004252258A1
- Authority
- AU
- Australia
- Prior art keywords
- image
- sample
- zone
- chamber
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 29
- 239000000126 substance Substances 0.000 title claims description 9
- 238000005259 measurement Methods 0.000 claims description 34
- 238000003556 assay Methods 0.000 claims description 17
- 238000004458 analytical method Methods 0.000 claims description 11
- 238000009792 diffusion process Methods 0.000 claims description 7
- 238000001069 Raman spectroscopy Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 230000003993 interaction Effects 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 3
- 239000000523 sample Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 15
- 238000001514 detection method Methods 0.000 description 13
- 239000011159 matrix material Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 230000005499 meniscus Effects 0.000 description 7
- 230000005284 excitation Effects 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 4
- -1 antibodies Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000010191 image analysis Methods 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000001454 recorded image Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000004557 single molecule detection Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
- G01N21/51—Scattering, i.e. diffuse reflection within a body or fluid inside a container, e.g. in an ampoule
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N15/0205—Investigating particle size or size distribution by optical means
- G01N15/0227—Investigating particle size or size distribution by optical means using imaging; using holography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
Landscapes
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Description
'est votre traduction! Informatique - Web A6ronautique Q Automobile Technique - Manuel d'utilisation Q Medical - Pharmaceutique uudiqtue' Fu nvir Commercial - Marketing COMMONWEALTH OF AUSTRALIA Patent Acts 1952/69 In the matter of Application for letters patent No. PCT/FR2004/050289 by DECLARATION A.R.T. International - 26, rue Carnot 95410 Groslay, France do hereby declare that we are conversant with the English and French languages and are a competent translator thereof. We declare further that the following is a true and correct translation made by us of the document in the French language attached hereto. Signed this 07th of November, 2005 B.P. 18 95410 GROSLAY T61 01.39.34.70.70 Fax: 01.39.34.70.77 S.A. au capital de 40 000 E - R.C.S. B 392 830 337 Q P 12 -QA I Ar.?0Q I AV METHOD FOR ASSAYING A BIOLOGICAL OR CHEMICAL SAMPLE Technical field This invention relates to a method for assaying a biological or chemical sample. The field- of the invention is in particular that of measuring the concentration of fluorescent molecules 5 called fluorochromes contained in solutions.. Such molecules are used to assay the amount of a given biological species. The number of molecules of this biological species is thus related to the amount of fluorescent molecules. A measurement of the intensity 10 emitted in the excitation of these fluorescent molecules makes it possible to deduce, by calibration of the measuring apparatus used, the number or concentration of biological molecules. Such measurements are routinely used in biology, chemistry 15 and physics. In the following description, for the sake of simplification, the invention is described in terms of this field of measuring the fluorescence of samples. 20 Prior art Many commercial apparatus, such as fluorimeters and spectro-fluorimeters, enable the fluorescence of a solution to be measured. These apparatuses make it possible to obtain a measurement in a chamber of which 25 the shape is variable and depends upon the application. Other apparatuses for measuring in solution use capillaries as a chamber. These are, for example, measuring systems for an electrophoresis apparatus.
2 In all of ~these apparatuses, a sample placed in a chamber, with which a single detector is associated, is measured. In some spectro-fluorimetry applications, multiple 5 detectors are used. The fluorescent molecule emission spectrum is then dispersed over an image sensor so as to simultaneously measure the energy in -all of the wavelengths, which amounts to the use of a single detector for each spectral interval. A plurality of 10 pixels are sometimes associated in the orthogonal direction with that of the dispersion so as to carry out a so-called "binning" operation which enables the signal-to-noise ratio of each spectral measurement to be increased while reducing the readout noise of the 15 detectors with the photon flow. Multiple detectors are also used in some multi-sample apparatuses. The presence of a plurality of samples then requires the use of a plurality of chambers, and the measurement for each sample is performed with an image sensor. 20 The detection sensitivity of such apparatuses is inadequate to assay small numbers of molecules, typically of the order of the picomole, either for diagnosing a disease or for studying the purity of a solution. Some assay types are even impossible to carry 25 out below a certain concentration: in the field of immunoanalysis (antigen assay), the statistical detection threshold of the prior art, expressed in terms of target concentration, the lowest obtained for a measurement in solution is of the order of one 30 hundred picomoles. Typically, commercial chamber 3 apparatuses do not enable a fluorescence below a target concentration of InM (nanomole) to be measured. To reduce the detection limit, the light of a laser source can be focused into a very small space, as 5 is done in capillary electrophoresis. The sample then passes into a capillary of a few hundred micrometers of diameter. The detection limit obtained is of the order of the nM, as described in reference document [1] at the end of the description. 10 Such a marker detection limit exists in a complex system comprising integrated confocal optics searching the interior of a capillary, as described in reference document [2]. The measuring systems use capillaries not allowing 15 for a very high sample rate, for example, of one dozen to one hundred microlitres/minute. It is therefore impossible to perform a measurement on a high-volume sample. The resulting selection reduces the molecular sampling and increases the detection threshold. For 20 example, if it is possible to detect the presence of a single molecule by fluorescence correlation techniques, as described in reference document [3], the probe volume is very small, of the order of a femtolitre. Detecting a molecule in such a volume gives a detection 25 limit of the order of a nM. To increase the power density in the excited volume, the excitation light can be focused. As the fluorescence emission is nearly proportional to the amount of energy received in the excitation, the 30 increase in power density enables the number of photons emitted in fluorescence to be increased. For a well- 4 designed measuring system, as is the case for most commercial instruments, the number of measured photons is greater and the uncertainty with regard to this measurement is lower. This uncertainty varies as 5 where N is the number of photons transformed into electrons during the conversion by the detector. This justifies the choice of an increase in power density in the excited volume. However, a high power density is accompanied by a photo-extinction, which is all the 10 more rapid as the light energy is high. For the measurement of a very low concentration of fluorescent molecules, it is then necessary to expose this volume for an amount of time greater than the photobleaching time, which corresponds to a property of the 15 fluorescent molecules consisting of stopping the emission of light at the end of a certain time period. It is then impossible to collect enough photons to reach the required detection threshold. Factors that limit the detection threshold lie in 20 the autofluorescence of liquids, which is an intrinsic fluorescence of these media, and in the Raman scattering. The level of emitted light indeed reduces detection performance because the photoluminescence "offset" of the buffer used is of the same nature as 25 the signal, i.e. "specific", to be detected. If the measuring system is only limited by the "Schottky noise", also called "photon noise", then the smallest statistically measurable signal Smin is equal to 3x VOffset , where "Offset" is a measurement expressed in 30 primary electrons (electrons resulting directly from 5 the conversion of photons by a photocathode in the case of a' photomultiplier or a semiconductor surface) and 3 is an arbitrary factor that guarantees 99 % discrimination between Smin and Offset. To solve such a 5 problem, the solutions of the prior art consist of: 1) a careful selection of liquids, 2) a selection of the marker, 3) an increase in the measuring time in. order to accumulate photons, 10 4) an increase in the excitation power in order to collect more photons. However, the main factor limiting the detection threshold is the non-reproducibility of the measurements, which, for low signal levels, becomes 15 dominant very quickly. This non-reproducibility essentially arises out of a poor mechanical repositioning of the measuring chamber and the light that is collected by the liquid meniscus in said chamber and which is randomly directed into the space. 20 A solution for reducing this type of non reproducibility consists of performing the injection in the chamber of a greater volume of solution. However, such an injection is adequate for obtaining good sensitivity. Moreover, it is not always possible or 25 desirable to work with large volumes. The mechanical positioning is not easy to improve. In addition, in such a solution, variations caused, for example, by ambient lighting and the variation in the form of the meniscus are not addressed. 30 Another solution for reducing this type of non reproducibility consists of using chambers including a 6 transparent "black" glass window, which corresponds to the zone taken into consideration for the measurement. This solution, however, reduces the photon 'flow collected by the measuring system, and therefore 5 increases the detection limit. Moreover, it does not enable the "offset" variations to be known, which can be caused by a change in the ambient light, by poor surface conditions on the sides of the chamber (soiling, scratches, and so on), or by a diffusion from the 10 meniscus and the walls. Thus, these various solutions of the prior art do not allow for good sensitivity or good reproducibility of the measurement. The aim of the invention is to overcome these 15 disadvantages by proposing a new method for assaying a biological or chemical sample that uses a device for spatial recording of the image of interaction between the light coming from a source and this sample as a means for selecting the necessary information. 20 Description of the invention The invention relates to a method for assaying a biological or chemical sample, comprising the following steps: 25 - optionally placing the sample in a chamber of which all of the sides are transparent, - lighting the sample by means of a light beam from a source, characterised in that it also comprises the 30 following steps: 7 - producing an image including the image of the light diffused by the sample, analysing : the image according to reference criteria, 5 - extracting information specific to the light/sample beam interaction, - calculating the assay. In this method, the diffusion can be Raman scattering, fluorescence scattering, molecular 10 diffusion or particle scattering. The analysis can consist of a study of the spatial structure of the image and of the distribution of light energy in this image. The assay can be calculated with respect to a calibration between the measurement of light energy and 15 the sample concentration or amount. The assay can also be calculated with respect to the analysis of the kinetics of the biological or chemical reaction. Advantageously, in this method, a first zone of interest around the excited volume zone, and a second 20 zone of interest next to this first zone are defined, and the specific signal is measured by carrying out the subtraction between the sum of all of the pixels of the first zone and the sum of all of the pixels of the second zone. 25 The invention has the following advantages: - It makes it possible to obtain a much lower -experimental detection limit than that of the conventional systems. - It makes it possible to perform an assay using a 30 large volume of solution with a high flow rate, and 8 therefore to consider applications such as the analysis of river waters and building ventilation systems. - It does not require the light to be focused in a small volume. The photobleaching of the fluorescent 5 molecules is therefore very low. - It makes it possible, due to the shape of the chamber, to simultaneously excite a large number of molecules, which enables numerous photons to be collected. 10 - Neither the autofluorescence nor the Raman scattering of the liquid medium limits the sensitivity of the invention. It therefore makes it possible to work with all commercial markers, thereby reducing the marking constraints. 15 - The non-reproducibility due to the chamber mechanics, cleaning or deterioration of the optical surfaces of the chamber, and the presence of artefacts (bubbles, dust) are no longer a constraint. The invention makes it possible, by image analysis, to 20 reduce and even eliminate these. A shift in the position of the chamber in the measuring system of the invention or a shift in the excitation light of the medium can be fully corrected after measuring the position of the fluorescent trace in the recorded image. 25 Similarly, dust present in the excited volume, which could significantly modify the measurement, is small with regard to the excited volume, and can thus be identified and removed from the measurement without losing the latter, which is impossible to perform with 30 a mono-detector. In the event of deterioration of the optical surfaces of the chamber, which can lead to a 9 modification in the amount of light that actually excites the sample, the invention enables the variations in the effective power to be known and the measurement to be corrected. 5 - The variations in ambient light caused either by the sample -or by the environment are compensated by a measurement of any "offsets" in the image, then the removal thereof. - The analysis of the information in an image can 10 be performed on the basis of predetermined elements (shading function, predetermined positions of the various useful zones), or dynamically in order to deal with random and/or unforeseen disturbances by applying image-processing methods (entropy maximisation, neural 15 network). - The dynamics of the assay of the invention, which, for a certain type of measurements, makes it possible to experimentally achieve biological assay dynamics of 2 200, is much higher than that of the 20 prior art, which, for the same type of measurements, is typically between 5 and 10. The invention can be applied to a number of fields, and, in particular: - in all of the fields where it is useful to 25 measure a fluorescent solution, - in biology, and more specifically for the assay of biological molecules or molecules of biological interest: antigens, antibodies, peptides, DNA, cells, bacteria, and so on, for a clinical diagnosis, 30 - in chemistry (assay), 10 - in pharmacy: assay of activity, contamination, and so on, - in physics: search for product traces, fluidic traces, mixture analysis, and so on. 5 Brief description of the drawings Figure 1 shows a bottom view of a first embodiment of a device implementing the method of the invention. Figures 2 and 3 show an image of the chamber 10 obtained with the image-recording device shown in figure 1. Figures 4 to 6 show a second embodiment of a device implementing the method of the invention. Figure 7 shows a third embodiment of a device 15 implementing the method of the invention. Figures 8 to 10 show three examples of an embodiment of a device implementing the method of the invention. 20 Detailed description of specific embodiments The method of the invention is a method for assaying (measuring a concentration or an amount) of a biological sample or a sample of biological interest (antigens, antibodies, peptides, DNA, cells, bacteria, 25 toxins) or a chemical sample (solvent, dissolved gas, preparation, chemical activity), which can be a solid, a liquid, a gel, and so on. In a first embodiment shown in figure. 1, a sample 10 is illuminated by a light beam 17 coming from a 30 source 11 provided with the fluorochrome used. For example, a 488-nm argon laser can be used for . 11 fluorescein or a helium-neon laser at 633 nm can be used for Cy5. The sample 10 is placed in a'-chamber 12, for example, with a rectangular cross-section, of which all of the sides are transparent. The cross section of 5 this chamber 12 can indeed be rectangular, square, cylindrical or ,elliptical. An objective system 13, equipped with a blocking filter 14, is mounted in front of a device for recording the spatial structure of an image 15, for example, a CCD camera or a scanning 10 system, connected to a processing component 16. The device 15 that receives the beam 18 diffused by the sample 10 makes it possible to record an image from which a specific measuring signal can be extracted. The method of the invention includes the following 15 steps: - illuminating the sample 10 by means of a light beam 17 coming from the source 11, which can be a gas laser, a solid laser, a laser diode, an electroluminescent diode, an organic diode, a spectral 20 bulb such as a halogen, mercury, xenon, or deuterium bulb, - producing an image of the light beam 18 diffused by the sample 10, wherein the origin of the diffusion can be Raman scattering, fluorescence scattering, 25 molecular diffusion (Rayleigh scattering) or particle scattering (use of nanoparticles), - analysing the image with respect to references, which analysis consists of examining the spatial structure of the image and the distribution of light 30 energy in this image, wherein said references can be constituted, for example, by the experience of a user 12 or by morphological criteria (form and position of a light trace), photometric criteria (frequency of spatial variations of the light in the image), or statistical criteria (variation of measurement 5 estimators, image entropy), - extracting information specific to the interaction between the beam 17 and a sample 10, which extraction consists, for example, of arithmetic operations between the image and other images or 10 constants (for example, subtractions, additions, divisions, multiplications), morphological operations (erosion, dilation, binarization, clipping, segmentations, offset correction) or photometric operations (polynomial corrections, convolutions, 15 filters, thresholding), - calculating the assay with respect to a calibration between the measurement of light energy and the concentration or quality of the biological or chemical sample. This calculation can also be performed 20 by recording the kinetics of the biological or chemical reaction and by analysing this kinetic using methods known to a person skilled in the art. In the-method of the invention, the measurement is performed in an image obtained by the device for 25 recording the spatial structure of an image 15. The invention does not lie in the use of such a device 15, but primarily in: - the recording of the beam 18 diffused by the sample 10 in the form of an image, 30 - the extraction of information from this image, 13 - the adaptive side obtained by the application of an image analysis. Figure 2 shows the image of the chamber 12 obtained, with the device for recording the spatial 5 structure of an image 15. The chamber can have smaller dimensions than those of the image. It can, for example, be replaced by one or more capillaries. In addition, the light beam can be either smaller or larger than the chamber. 10 In this image, a plurality of zones can be distinguished: - an illuminated volume zone 20, which corresponds to the volume of the chamber 12 excited by the beam 17, - the zone 21 where said beam 17 enters the 15 chamber 12, - the zone 22 where said beam 17 exits the chamber 12, - a meniscus zone 23, - an artefact zone 24. 20 Thus, as shown in figure 3, it is possible to define a first region of interest 25 around the illuminated volume zone 20 and a second region of interest 26 next to this zone 25. The measurement of the specific signal is then given by the calculation: 25 ERIi-ERI2; that is, the subtraction between the sum of all of the pixels of the first region of interest 25 and the sum of all of the pixels of the second region of interest 26. In figure 3, the two regions of interest 25 and 26 30 have the same size, which is not essential. When these regions do not have the same size, it is simply 14 necessary either to average the grey levels of each region, or to balance the values by the number of pixels. The image analysis thus represented leads to 5 certain observations: - The fluorescent trace of the light beam (zone 20) gives the specific signal. - The meniscus (zone 23), delimiting the liquid from the air, has a strong light. It originates from 10 said trace. The form of this meniscus is highly randoft. The amplitude of the signal coming from this meni-scus is therefore highly variable. - An artefact (zone 24) can be, for a given assembly, a spring lock washer designed to ensure the 15 proper mechanical positioning of the chamber 12. - The zones 21 and 22 correspond respectively to the points of entry and exit of the light beam in the chamber 12. With another adjustment of the display thresholds, 20 it is easier to show the lowest light levels. The method of the invention makes it possible to improve the variation coefficient (CV) (standard deviation/mean) . Indeed, the coefficient CV obtained with the method of the invention is lower than the 25 coefficient CV calculating by obtaining the sum of all of the pixels of a CCD camera, which corresponds to a measurement performed with a mono-detector. The coefficient CV obtained with the method of the invention is of the same order of magnitude as that 30 obtained with a high solution volume, as considered previously in the introduction to said application.
15 This coefficient CV obtained with the method of the invention is lower than that obtained by the measurement in each of the zones of interest 25 and 26. The subtraction of the measurements performed. in these 5 two zones of interest makes it possible to correct lighting variations that affect all of the regions. The invention thus makes it possible to perform spatial filtering in the plane that enables the signal containing specific information on the fluorescence to 10 be extracted. Moreover, the invention makes it possible to extract the regions of interest which are truly relevant in an image or a pseudo-image, while a measuring system using a single mono-pixel detector cannot perform such a function. 15 In a second embodiment, a mono-detector associated with a matrix of pixels with programmable transparency 30 such as a liquid crystal or micro-mirror matrix or any other equivalent system is placed in front of the chamber 12 shown in figure 4. This matrix 30 is 20 intercalated between the chamber 12 and the detector via a system for forming images or not. A first measurement is then performed by "opening" the pixels corresponding to the first zone of interest 25, as shown in figure 5, then a second measurement is 25 performed by opening the pixels corresponding to the second zone of interest 26, as shown in figure 6. The use of such a matrix 6 with variable transparency makes it possible to avoid the systematic recording of an image, for example, by performing the 30 following steps: 16 - recording the image of the beam diffused by successively opening/closing all of the pixels of the matrix 30 in synchronisation with the measurement carried out by the mono-detector, 5 - analysing the image and defining the zone(s) of interest enabling the specific information to be extracted, - recording such parameters for a subsequent use, - in the analysis of a given sample, performing 10 successive openings of regions defined in the analysis step and recording the results of the measurement for each of these zones, - extracting the necessary information, - calculating the assay. 15 In a third embodiment shown in figure 7, two mono pixel detectors 35 and 36 each observe a region of interest 25 or 26. Two image formation means 37 and 38 are placed respectively in front of each of these two detectors 35 and 36. The measurement of the signal 20 coming from the first region of interest 25 is performed with detector 35, and that for the second region of interest 26 is performed with detector 36. The zone 39 shows the front view of the fluorescent trace. 25 The invention makes it possible to adapt the extraction of the specific signal to experimental conditions. For example, if the chamber has moved between two series of measurements, it is possible, by an automatic analysis of the. image, to automatically 30 reposition the regions of interest, an operation that could not be performed with a static system.
17 Examples of embodiments of the invention The three examples of embodiments described below correspond respectively to the three embodiments 5 defined above. In a first example of an embodiment shown in figure 8, a light source 40, for: example a laser or an electroluminescent diode, excites, in a chamber 41, the liquid containing fluorescent molecules through optics 10 with a configuration that is not shown, and various accessories such as a shutter 42 and a diaphragm 43. A first objective 44, placed, for example, perpendicularly with respect to the primary direction of the light beam, collects a portion of this light 15 beam, emitted by fluorescent molecules in the chamber 41. A blocking filter 45 is placed behind the first objective 44, just in front of a second objective 46. The association of objectives 44 and 46 enables an image of the chamber 41 to be formed on the image 20 detector 47 which is connected to a command and control system 49. For a chamber 41 with an internal width of 1 cm, this detector 47 can be a detector of 512 x 512 pixels with a side of 10 pm. The first objective 44 can have a focal length of 50 mm and the second objective 25 46 can have a focal length of 25 mm. In a second example of an embodiment, shown in figure 9, of which the configuration is the same as that of figure 8 for excitation, only one detector is used. A matrix 56 with variable transparency, which can 30 be a liquid crystal matrix or a micromirror matrix, acts as a field diaphragm. The matrix 56 can be 18 replaced by a mobile window actuated by a mechanical or electromechanical actuator, for example an electromagnet or an electric motor. In a third example of an embodiment shown in 5 figure 10, the configuration for exciting the inside of the chamber 41 is the same as in figure 8, and the configuration for the light collection is the same as that in figure 9. Two mono-detectors 50 and 51, for example, offset photomultipliers, enable two different 10 regions of the chamber 41 to be observed. In front of each detector 50 and 51, recapture optics 52 and 53 enable the image of the region of interest to be formed on a field diaphragm 54 and 55, which limits the region observed. A blocking filter can be placed in front of, 15 in or behind the diaphragm. The zone 56 represents the fluorescent trace.
19 REFERENCES [1] "Some applications of near-ultraviolet laser induced fluorescence detection in nanomolar- and subnanomolar-range high-performance liquid chromatography or micro-high performance liquid 5 chromatography" by N. Sim6on, R. Myers, C. Bayle, M. Nertz, J.K. Stewart, F. Couderc (2001, Journal of Chromatography A, Vol 913, I 1-2, pages 253-259). [2] "Performance of an integrated microoptical 10 system for fluorescence detection in microfluidic systems" by J.C. Roulet, R. Volkel, H.P. Herzig, E. Verpoorte, N.F. Rooij, R. Dandliker (2002, Analytical Chemistry, Vol. 74 (14), pages 3400-3407). 15 [3] "Single molecule detection of specific nucleic acid sequences in unamplified genomic DNA" by A. Castro and J.G. Williams (1997, Analytical Chemistry, Vol. 69 (19), pages 3915-3920).
Claims (7)
1. Method for assaying a biological or chemical sample, comprising a step of illuminating the sample (10) by means of a light beam (17) coming from a source (11), 5 characterised in that it also comprises the following steps: - producing an image including the image of the beam (18) diffused by the sample (10), - analysing the image according to reference 10 criteria, - extracting information specific to the light/sample beam interaction, - calculating the assay, and in that the analysis consists of the 15 examination of the spatial structure of the image and the distribution of the light energy in this image.
2. Method according to claim 1, which comprises a previous step of placing the sample (10) in a chamber 20 (12) of which all of the sides are transparent.
3. Method according to claim 1, characterised in that the diffusion is Raman scattering, fluorescence scattering, a molecular diffusion or particle 25 scattering.
4. Method according to claim 1, in which the assay is calculated with respect to a calibration between the 21 light energy measurement and the sample concentration or amount.
5. Method according to claim 1, in which the assay 5 is calculated with respect to the analysis of the kinetics of the biological or chemical reaction.
6. Method according to claim 1, in which a first zone of interest (25) around the excited volume zone, 10 and a second zone of interest (26) next to this first zone are defined, and the specific signal is measured by subtracting the sum of all of the pixels of the first zone (25) from the sum of all of the pixels of the second zone (26). 15
7. Application of the method according to any one of the claims preceding the fluorescence.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0350270 | 2003-06-27 | ||
FR0350270A FR2856792B1 (en) | 2003-06-27 | 2003-06-27 | METHOD AND DEVICE FOR ASSAYING A BIOLOGICAL OR CHEMICAL SAMPLE |
PCT/FR2004/050289 WO2005001449A1 (en) | 2003-06-27 | 2004-06-24 | Method for dosing a biological or chemical sample |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2004252258A1 true AU2004252258A1 (en) | 2005-01-06 |
Family
ID=33515557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2004252258A Abandoned AU2004252258A1 (en) | 2003-06-27 | 2004-06-24 | Method for dosing a biological or chemical sample |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1639349A1 (en) |
JP (1) | JP2007516411A (en) |
AU (1) | AU2004252258A1 (en) |
CA (1) | CA2530382A1 (en) |
FR (1) | FR2856792B1 (en) |
WO (1) | WO2005001449A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5097590B2 (en) * | 2008-03-26 | 2012-12-12 | 富士フイルム株式会社 | Raman signal measuring method and Raman signal measuring apparatus |
FR2938917B1 (en) * | 2008-11-26 | 2018-05-18 | Formulaction | DEVICE FOR ANALYZING A POLYPHASIC MIXTURE VIA A LIGHT BEAM RETRODIFFUSED THEREBY |
AU2020379227A1 (en) * | 2019-11-08 | 2022-04-21 | Nanotemper Technologies Gmbh | Characterization of particles in solution |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797937A (en) * | 1972-03-01 | 1974-03-19 | Environmental Systems Corp | System for making particle measurements |
DE3206407A1 (en) * | 1982-02-23 | 1983-09-01 | Gesellschaft für Strahlen- und Umweltforschung mbH, 8000 München | Apparatus for the quantitative detection of biochemical reactions |
JP2799191B2 (en) * | 1989-08-24 | 1998-09-17 | オリンパス光学工業株式会社 | Method for forming two-dimensional concentration distribution image of intracellular ions |
US5323010A (en) * | 1992-12-01 | 1994-06-21 | I.S.S. (Usa) Inc. | Time resolved optical array detectors and CCD cameras for frequency domain fluorometry and/or phosphorimetry |
JP3224640B2 (en) * | 1993-07-30 | 2001-11-05 | 三菱重工業株式会社 | Apparatus and method for measuring concentration by LIF |
JP3290786B2 (en) * | 1993-11-26 | 2002-06-10 | シスメックス株式会社 | Particle analyzer |
JPH0933441A (en) * | 1995-07-19 | 1997-02-07 | Toray Ind Inc | Method and device for judging reaction pattern |
US5827660A (en) * | 1996-08-09 | 1998-10-27 | University Of Massachusetts | Caged fluorochrome-labeled probes and subtraction of autoflourescence background |
JPH1078398A (en) * | 1996-09-02 | 1998-03-24 | Bunshi Bio Photonics Kenkyusho:Kk | Fluorescence sevice life measuring device and method |
DE19915310A1 (en) * | 1999-04-03 | 2000-10-05 | Bayer Ag | Diffusion-controlling sensor layer |
JP2001083092A (en) * | 1999-09-17 | 2001-03-30 | Kowa Co | Fluorescent particle image pickup device |
JP3576523B2 (en) * | 2000-12-26 | 2004-10-13 | オリンパス株式会社 | Fluorescence luminance measurement method and apparatus |
JP3715248B2 (en) * | 2001-03-21 | 2005-11-09 | オリンパス株式会社 | Biochemical inspection method |
-
2003
- 2003-06-27 FR FR0350270A patent/FR2856792B1/en not_active Expired - Fee Related
-
2004
- 2004-06-24 JP JP2006516356A patent/JP2007516411A/en active Pending
- 2004-06-24 AU AU2004252258A patent/AU2004252258A1/en not_active Abandoned
- 2004-06-24 CA CA002530382A patent/CA2530382A1/en not_active Abandoned
- 2004-06-24 WO PCT/FR2004/050289 patent/WO2005001449A1/en active Application Filing
- 2004-06-24 EP EP04767851A patent/EP1639349A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2530382A1 (en) | 2005-01-06 |
JP2007516411A (en) | 2007-06-21 |
EP1639349A1 (en) | 2006-03-29 |
WO2005001449A1 (en) | 2005-01-06 |
FR2856792A1 (en) | 2004-12-31 |
FR2856792B1 (en) | 2006-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10753861B2 (en) | Methods for colorimetric analysis | |
JP4286447B2 (en) | Digital imaging system for assays in well plates, gels and blots | |
JP4170947B2 (en) | Biological sample component detection method and apparatus | |
US7057721B2 (en) | Wide field method for detecting pathogenic microorganisms | |
US6654119B1 (en) | Scanning spectrophotometer for high throughput fluroescence detection | |
US7027932B2 (en) | Biochemical examination method | |
JP2008281571A (en) | Apparatus for reading signals generated from resonance lightscattered particle labels | |
US20090305909A1 (en) | Method and System for Multiplex Genetic Analysis | |
US20240027325A1 (en) | Method and apparatus for flow-based, single-particle and/or single-molecule analysis | |
US7396650B2 (en) | Method for dosing a biological or chemical sample | |
AU2004252258A1 (en) | Method for dosing a biological or chemical sample | |
KR101979287B1 (en) | Methods and systems for image data processing | |
JP2021189183A (en) | Information processing device, biological specimen analysis method, biological specimen detection device, and biological specimen detection system | |
US20230175966A1 (en) | Wide-area-sample based reader design for diagnostic detection of bio-particles | |
Yuan et al. | Microchip imaging cytometer: making healthcare available, accessible, and affordable | |
JP2009270931A (en) | Observation device of single nucleic acid molecule | |
JP3834519B2 (en) | Biochemical inspection method | |
WO2021182031A1 (en) | Particle analysis system and particle analysis method | |
Nieman et al. | Hyperspectral imaging system for quantitative identification and discrimination of fluorescent labels in the presence of autofluorescence | |
Netaev | Single photon avalanche diode (SPAD) array detectors for luminescence based biomedical applications | |
Yorulmaz et al. | Single-particle imaging for biosensor applications | |
van den Doel et al. | Monitoring enzyme-catalyzed reactions in micromachined nanoliter wells using a conventional microscope-based microarray reader | |
JP2004325396A (en) | Sensitivity evaluation method for signal reader | |
Bell et al. | An integrated digital imaging system and microarray mapping software for rapid multiplexed quantitation of protein microarray immunoassays | |
Walczak | Image sensor-based fluorescence detection for microfluidical chips |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |